Latest news
DFTX: Strong Phase 3 efficacy data and robust cash position support continued pipeline advancement - TradingViewTradingView · Thu, 06 Aug 2026 20:07:24 GMTRAPP: RAP-219 shows robust efficacy in drug-resistant epilepsy, advancing to Phase 3 with strong financial backing - TradingViewTradingView · Wed, 05 Aug 2026 13:38:22 GMTQTTB: Bempikibart shows strong efficacy and safety in severe alopecia areata, supporting Phase 3 advancement - TradingViewTradingView · Wed, 05 Aug 2026 11:39:41 GMTQTTB: Strong 36-week efficacy data and $200M financing position support late-stage bempikibart trials - TradingViewTradingView · Wed, 05 Aug 2026 11:11:52 GMTClarity Pharmaceuticals Reports Further Strong Efficacy and Favourable Safety from SECuRE Prostate Cancer Trial - Finance News NetworkFinance News Network · Wed, 05 Aug 2026 02:30:29 GMTMRK: Once-weekly and monthly oral HIV regimens show strong efficacy, targeting $5B+ by mid-2030s - TradingViewTradingView · Mon, 03 Aug 2026 14:58:41 GMTMRK: Long-acting oral HIV regimens show strong efficacy and market potential, targeting $5B+ by mid-2030s - TradingViewTradingView · Mon, 03 Aug 2026 14:08:31 GMTMRK: Once-weekly oral HIV regimens show high efficacy, safety, and strong patient preference - TradingViewTradingView · Mon, 03 Aug 2026 12:32:31 GMT